Literature DB >> 22157616

Lentiviral infection of rhesus macaques causes long-term injury to cortical and hippocampal projections of prostaglandin-expressing cholinergic basal forebrain neurons.

Candan Depboylu1, Eberhard Weihe, Lee E Eiden.   

Abstract

The simian immunodeficiency virus (SIV) macaque model resembles human immunodeficiency virus-acquired immunodeficiency syndrome (AIDS) and associated brain dysfunction. Altered expression of synaptic markers and transmitters in neuro-AIDS has been reported, but limited data exist for the cholinergic system and lipid mediators such as prostaglandins. Here, we analyzed cholinergic basal forebrain neurons with their telencephalic projections and the rate-limiting enzymes for prostaglandin synthesis, cyclooxygenase isotypes 1 and 2 (COX1 and COX2) in the brains of SIV-infected macaques with or without encephalitis and antiretroviral therapy and uninfected controls.Cyclooxygenase isotype 1, but not COX2, was coexpressed with markers of cholinergic phenotype, that is, choline acetyltransferase and vesicular acetylcholine transporter (VAChT), in basal forebrain neurons of monkey, as well as human, brain. Cyclooxygenase isotype 1 was decreased in basal forebrain neurons in macaques with AIDS versus uninfected and asymptomatic SIV-infected macaques. The VAChT-positive fiber density was reduced in frontal, parietal, and hippocampal-entorhinal cortex. Although brain SIV burden and associated COX1- and COX2-positive mononuclear and endothelial inflammatory reactions were mostly reversed in AIDS-diseased macaques that received 6-chloro-2',3'-dideoxyguanosine treatment, decreased VAChT-positive terminal density and reduced cholinergic COX1 expression were not. Thus, COX1 expression is a feature of primate cholinergic basal forebrain neurons; it may be functionally important and a critical biomarker of cholinergic dysregulation accompanying lentiviral encephalopathy. These results further imply that insufficiently prompt initiation of antiretroviral therapy in lentiviral infection may lead to neurostructurally unremarkable but neurochemically prominent irreversible brain damage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22157616      PMCID: PMC3258462          DOI: 10.1097/NEN.0b013e31823cfac5

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  55 in total

1.  Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor.

Authors:  W Fischer; K Wictorin; A Björklund; L R Williams; S Varon; F H Gage
Journal:  Nature       Date:  1987 Sep 3-9       Impact factor: 49.962

2.  Necropsy evidence of central cholinergic deficits in senile dementia.

Authors:  E K Perry; R H Perry; G Blessed; B E Tomlinson
Journal:  Lancet       Date:  1977-01-22       Impact factor: 79.321

Review 3.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

4.  Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry.

Authors:  M M Mesulam; E J Mufson; A I Levey; B H Wainer
Journal:  Neuroscience       Date:  1984-07       Impact factor: 3.590

5.  Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey.

Authors:  M M Mesulam; E J Mufson; A I Levey; B H Wainer
Journal:  J Comp Neurol       Date:  1983-02-20       Impact factor: 3.215

Review 6.  Implications of the neuropathology of HIV encephalitis for the pathogenesis of Alzheimer disease.

Authors:  C A Wiley
Journal:  Alzheimer Dis Assoc Disord       Date:  1987       Impact factor: 2.703

7.  Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions.

Authors:  M Ruberg; W Mayo; A Brice; C Duyckaerts; J J Hauw; H Simon; M LeMoal; Y Agid
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

Review 8.  The cholinergic hypothesis of geriatric memory dysfunction.

Authors:  R T Bartus; R L Dean; B Beer; A S Lippa
Journal:  Science       Date:  1982-07-30       Impact factor: 47.728

9.  Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients.

Authors:  H Henke; W Lang
Journal:  Brain Res       Date:  1983-05-16       Impact factor: 3.252

10.  Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.

Authors:  T D Bird; S Stranahan; S M Sumi; M Raskind
Journal:  Ann Neurol       Date:  1983-09       Impact factor: 10.422

View more
  6 in total

1.  Acute Response of the Hippocampal Transcriptome Following Mild Traumatic Brain Injury After Controlled Cortical Impact in the Rat.

Authors:  Babru B Samal; Cameron K Waites; Camila Almeida-Suhett; Zheng Li; Ann M Marini; Nihar R Samal; Abdel Elkahloun; Maria F M Braga; Lee E Eiden
Journal:  J Mol Neurosci       Date:  2015-08-29       Impact factor: 3.444

2.  Astrocytic expression of HIV-1 Nef impairs spatial and recognition memory.

Authors:  Gladys Chompre; Emmanuel Cruz; Lucianette Maldonado; Vanessa Rivera-Amill; James T Porter; Richard J Noel
Journal:  Neurobiol Dis       Date:  2012-08-25       Impact factor: 5.996

3.  Nicotine attenuates the effect of HIV-1 proteins on the neural circuits of working and contextual memories.

Authors:  Tanseli Nesil; Junran Cao; Zhongli Yang; Sulie L Chang; Ming D Li
Journal:  Mol Brain       Date:  2015-07-24       Impact factor: 4.041

4.  Whole-Brain Monosynaptic Afferent Inputs to Basal Forebrain Cholinergic System.

Authors:  Rongfeng Hu; Sen Jin; Xiaobin He; Fuqiang Xu; Ji Hu
Journal:  Front Neuroanat       Date:  2016-10-10       Impact factor: 3.856

5.  Loss of cerebellar neurons in the progression of lentiviral disease: effects of CNS-permeant antiretroviral therapy.

Authors:  Christian Wächter; Lee E Eiden; Nedye Naumann; Candan Depboylu; Eberhard Weihe
Journal:  J Neuroinflammation       Date:  2016-10-14       Impact factor: 8.322

6.  Attenuated SIV causes persisting neuroinflammation in the absence of a chronic viral load and neurotoxic antiretroviral therapy.

Authors:  Deborah Ferguson; Sean Clarke; Neil Berry; Neil Almond
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.